Application note: Real-time kinetic analysis of Akt activity
Cell signalling through the Akt pathway controls numerous key cellular functions including proliferation, survival, and migration.
List view / Grid view
Cell signalling through the Akt pathway controls numerous key cellular functions including proliferation, survival, and migration.
Researchers from the University of Pennsylvania have developed a novel organ-on-a-chip technology called OCTOPUS, an optimised device for growing mini-organs in a dish.
Cell proliferation assays are a cornerstone of cancer therapeutic, developmental biology, and drug safety research.
Israeli researchers develop new model that will help pinpoint complications in individuals with Differences in sex development (DSD).
Discover the Incucyte® Scratch Wound Analysis Software Module for automated image-based measurements of cell migration in vitro, using label-free analysis.
The scientists hope the human body plan will increase the understanding of the aetiology and pathology of disease.
Read about the current state of the industry, challenges associated with potency assays and measuring product potency throughout the manufacturing process.
Understand how quality control assays are being implemented in monitoring the development of CAR-T cells using high-throughput technologies in this article.
This application note discusses why CAR T-cell therapy is so exciting, notes some common hurdles in development and manufacturing and proposes ddPCR technology as a solution for some of these issues.
Mouse models show that activating a non-mutated form of the gene could lead to developing therapies for salivary gland cancer.
Join our experts as they discuss factors causing variability issues in organoids and how to avoid them.
Discover how a plasmid DNA manufacturing platform process is helpful from preclinical studies to scaling production for late-stage and commercial needs.
The findings provide insight into how genetics can make someone more susceptible to developing PTSD following trauma exposure.
This whitepaper reviews the drug discovery progress for neurodegenerative diseases, focusing on promising candidates identified using iPSC technology.
UCLA-led team discovers that using early-stage stem cells is a key to producing structures that are reliable models of disease.